Patents by Inventor Maria Schuster

Maria Schuster has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Transgenic non-human animals expressing human blood clotting factors and uses thereof
    Patent number: 8962912
    Abstract: The present invention relates, in general, to development of non-human transgenic animals expressing a human blood clotting factor, such as Factor VIII, Factor VII, Factor IX and von Willebrand factor. The invention further provides methods of detecting immunogenic events against human blood clotting factor using the transgenic animals described.
    Type: Grant
    Filed: March 24, 2011
    Date of Patent: February 24, 2015
    Assignees: Baxter International Inc., Baxter Healthcare SA
    Inventors: Maria Sasgary, Maria Schuster, Hans-Peter Schwarz, Birgit Maria Reipert, Gerhard Antoine, Hartmut Ehrlich
  • Transgenic Non-Human Animals Expressing Human Blood Clotting Factors and Uses Thereof
    Publication number: 20120082987
    Abstract: The present invention relates, in general, to development of non-human transgenic animals expressing a human blood clotting factor, such as Factor VIII, Factor VII, Factor IX and von Willebrand factor. The invention further provides methods of detecting immunogenic events against human blood clotting factor using the transgenic animals described.
    Type: Application
    Filed: March 24, 2011
    Publication date: April 5, 2012
    Applicants: BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE S.A.
    Inventors: Maria Sasgary, Maria Schuster, Hans-Peter Schwarz, Birgit Reipert, Gerhard Antoine, Hartmut Ehrlich
  • Transgenic Non-Human Animals Expressing Human Blood Clotting Factors and Uses Thereof
    Publication number: 20090235369
    Abstract: The present invention relates, in general, to development of non-human transgenic animals expressing a human blood clotting factor, such as Factor VIII, Factor VII, Factor IX and von Willebrand factor. The invention further provides methods of detecting immunogenic events against human blood clotting factor using the transgenic animals described.
    Type: Application
    Filed: December 30, 2008
    Publication date: September 17, 2009
    Applicants: BAXTER HEALTHCARE S.A., BAXTER INTERNATIONAL INC.
    Inventors: Maria Sasgary, Maria Schuster, Hans-Peter Schwarz, Birgit Reipert, Gerhard Antoine, Hartmut Ehrlich